Table 1.

A proactive agenda to promote elimination of all species of human malaria

Surveillance of Plasmodium vivax in new populations and expansion of the P. vivax elimination agenda to include sub-Saharan Africa

Geospatial mapping of glucose 6-phosphate dehydrogenase deficiencies and CYP2D6 to gage populations at risk of primaquine-induced hemolysis and poor efficacy

Optimizing drug treatment of P. vivax, Plasmodium ovale, Plasmodium malariae, and Plasmodium knowlesi

Ensure effective radical cure of malaria through improved adherence or short-duration treatment regimens

Reestablish field entomology as a core component of malariology

Incorporation of ecology (including environmental control methods) into malaria planning, where appropriate

Increase sampling of parasite reservoirs in areas with potential zoonotic transmission (human and nonhuman primate) and phylogeny of parasite populations to asses “spillover”

Identification and optimization of strategies to target zoonotic malaria infections

Greater emphasis on the basic biology of P. knowlesi, P. ovale, and P. malariae